Massarweh S,Schiff R . Resistance to endocrine therapy in breast cancer:exploiting estrogen receptor/growth factor signaling crosstalk .Phase Ⅲ trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patien ......